Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Figure 5

Forest plot of SCORAD index, % BSA, PSAAD index, and POEM index (100 mg abrocitinib vs. placebo).